Stem cells from human hair follicles: first mechanical isolation for immediate autologous clinical use in androgenetic alopecia and hair loss

Size: px
Start display at page:

Download "Stem cells from human hair follicles: first mechanical isolation for immediate autologous clinical use in androgenetic alopecia and hair loss"

Transcription

1 Orignial rticle Page 1 of 10 Stem cells from human hair follicles: first mechanical isolation for immediate autologous clinical use in androgenetic alopecia and hair loss Pietro Gentile 1,2, Maria G. Scioli 3, lessandra ielli 3, ugusto Orlandi 3, Valerio Cervelli 1 1 Department of 3 Contributions: approval of manuscript: ll authors. Correspondence to: ackground: in vivo Methods: Results: Conclusions: Keywords: View this article at: Introduction Eighty percent of Caucasian men experience some degree of androgenetic alopecia (G) before age 70 (1). Stem Cell Investig 2017;4

2 Page 2 of 10 Stem Cell Investigation, 2017 of resting (telogen) hair follicles containing microscopic hairs in bald scalp (5). In addition to these intrinsic changes suggests that balding scalp either lacks an activator or has Current regulations In order to understand the sense of the current European of bioprocessing of therapeutic cells. the European Parliament (EC) and of the Council 13 Included among the advanced therapy pharmaceutical products are those used for gene and somatic cell therapy Cells and tissues are to be considered products of bioprocess ll cells that have undergone a manipulation of their ccording to reflection paper on classification of The same essential function for a cell population means that the cells when removed from their original environment in the human body are used to maintain the original function in the same anatomical or histological environment Clinical Practices (GCP) for the clinical application and Ethical Committee approval. Methods Patients 3

3 Stem Cell Investigation, 2017 Page 3 of 10 C D Figure 1 Human autologous hair follicle suspension procedure and preparation Italy) (Figure 1,). fter the extraction of the scalp tissues during punch biopsy (Figure 1C Figure 1D) collected and disaggregated under sterile conditions (vertical Figure 2,) in Figure 2C). (Figure 2D system (Figure 3,) and mechanically infiltrated into the scalp of the patients affected by G (Figure 3C,D). Human autologous hair follicle suspension protocol and injection Figure 3D

4 Page 4 of 10 Stem Cell Investigation, 2017 C D Figure 2 Figures 3C,5 Figure 5 the border of the treatment half and a second along the permanent tattoo. ssessment of hair growth and clinical evaluation of study (Figure 4Figure 4 Figure 4C after the last treatment (Figure 4D Cytospin and immunocytochemistry procedures respectively. fter cell adhesion on a glass slide by

5 Stem Cell Investigation, 2017 Page 5 of 10 C D Figure 3 Results treated scalp. ( Figure 6 Figure 6 Clinical results mean hair count and hair density increases (Figure 4D) over baseline values (Figure 4 increase in hair density for the treated area and less than control area of the scalp. Discussion

6 Page 6 of 10 Stem Cell Investigation, 2017 C D Figure 4 Figure 5

7 Stem Cell Investigation, 2017 Page 7 of 10 Figure 6 follicle from dissociated cells propagated under defined tissue culture conditions is a challenge still pending in tissue engineering (11). It is then of great interest to find different strategies aiming to regenerate or neogenerate the hair follicle under interactions during the embryonic hair generation and adult hair follicles using different strategies and approaches depending on the causes of hair loss (11). centrifugation of punch biopsy from human hair follicles the preliminary results obtained by the human follicle stem improving hair density. current advances in the different experimental strategies on those involving neogenesis of hair follicles in adult individuals using isolated cells and tissue engineering. follicles from adult cells has yet been reported. Perhaps dimensional culture conditions mimicking the structure human hair follicle neogenesis (11). in vivo system et al. in the hair follicles in vivo expressed in pluripotent cells of the developing embryo and

8 Page 8 of 10 Stem Cell Investigation, 2017 follicles are related to these pluripotent stem cells that can environmental cues. et al. cells in human skin are located in the areas highlighted by in vivo contain multipotent stem cells other than epithelial and ex vivo and in vitro for cell engineering and cell replacement therapies. that hair spheres can be generated from autologous adult based therapies. involved in this crosstalk at different hair cycle stages and process called hair follicle neogenesis. approaches have been designed to regenerate hair follicles (II) regeneration of complete hair follicles from the follicles by tissue engineering. follicle regeneration retaining the information to determine limitation different approaches and experimental models using freshly or cultured isolated cells from both dermal involved neonatal and embryonic murine cells. et al. (11) cultured hair follicle epithelial stem cells and dermal histological structures reminiscent of many different stages present in epithelial cells of the companion layer. lthough cultured cells from adult human scalp in a dermal scaffold in vivo structures that recapitulate embryonic hair development. conclusion that hair follicle neogenesis using human embryonic or neonatal cells.

9 Stem Cell Investigation, 2017 Page 9 of 10 the possibility to use human follicle stem cells obtained by Conclusions preparations has a positive therapeutic effect on male the authors recommend future study and clinical trials cknowledgements Footnote to declare. Ethical Statement: all patients. References proliferation and multipotent potential of human hair and skin tissue engineering in hair follicle regeneration. population of multipotent adult stem cells from human follicular stem cells in forming not only the follicle but stem cell activation during hair regeneration. Cell Stem differentiation of adult epithelial stem cells from human

10 Page 10 of 10 Stem Cell Investigation, 2017 Cite this article as: isolation for immediate autologous clinical use in androgenetic

Stem Cel s Key Words:

Stem Cel s Key Words: Stem Cells Key Words: Embryonic stem cells, Adult stem cells, ips cells, self-renewal, differentiation, pluripotent, multipotent, Inner cell mass, Nuclear transfer (Therapeutic cloning), Feeder cells,

More information

Regulatory requirements for cell based medicinal products

Regulatory requirements for cell based medicinal products Regulatory requirements for cell based medicinal products 資料 3-2 Committee 25 August 2010 Dr. Bettina Klug, MSc Paul-Ehrlich-Institut, Langen klube@pei.de Paul-Ehrlich-Institut Federal Institute for Vaccines

More information

ANAT 2341 Embryology Lecture 18 Stem Cells

ANAT 2341 Embryology Lecture 18 Stem Cells ANAT 2341 Embryology Lecture 18 Stem Cells 29 September 2010 Dr Antonio Lee Neuromuscular & Regenera

More information

Stem Cells: Introduction and Prospects in Regenerative Medicine.

Stem Cells: Introduction and Prospects in Regenerative Medicine. Stem Cells: Introduction and Prospects in Regenerative Medicine www.gothamgazette.com/.../stemcell/stem_cell.jpg Ode to a Stem Cell, Part II by VCW There once was stem cell stuck in the hood Dividing endlessly,

More information

Regulatory Perspectives of Japan

Regulatory Perspectives of Japan International Alliance for Biological Standardization (IABS) Challenge Toward Sound Scientific Regulation of Cell Therapy Products at Kyoto International Conference Center, Kyoto, Japan Regulatory Perspectives

More information

Agenzia Italiana del Farmaco

Agenzia Italiana del Farmaco Agenzia Italiana del Farmaco European Regulation on Advanced Therapies Cristina Pintus Head of European Relations Unit and Coordinator of the Advanced Therapy Project Italian Medicines Agency Proposal

More information

Science Dialogue. By: Dr. Ahmed Hegab, PhD Dr. Hiroshi Kubo, MD, PhD. Hachinohe-Kita High School

Science Dialogue. By: Dr. Ahmed Hegab, PhD Dr. Hiroshi Kubo, MD, PhD. Hachinohe-Kita High School Science Dialogue at Hachinohe-Kita High School By: Dr. Ahmed Hegab, PhD Dr. Hiroshi Kubo, MD, PhD Department of Geriatric and Respiratory Medicine, Tohoku University School of Medicine Topics of today

More information

Regulation of Cell and Gene Therapy Products in Canada

Regulation of Cell and Gene Therapy Products in Canada Regulation of Cell and Gene Therapy Products in Canada Canadian Blood and Bone Marrow Transplant Group June 8, 2018 Nadine Kolas, PhD Senior Policy Analyst Blood, Cells, Tissues and Organs Biologics and

More information

THE THERAPEUTIC REALITIES OF STEM CELLS

THE THERAPEUTIC REALITIES OF STEM CELLS Ferghana Partners Group is a Life Sciences investment banking house with offices in London and New York. We specialise in creating and executing effective strategic transactions for pharmaceutical, chemical,

More information

Stem cells for therapeutic use

Stem cells for therapeutic use Transition to an industrial scale of human stem cell production for therapeutic use by Bruno JARRY, Jean-François STOLTZ and Raymond ARDAILLOU on behalf of a working group joining Academy of Technologies

More information

Unit 1: DNA and the Genome. Sub-Topic (1.4) Cellular Differentiation

Unit 1: DNA and the Genome. Sub-Topic (1.4) Cellular Differentiation Unit 1: DNA and the Genome Sub-Topic (1.4) Cellular Differentiation Duncanrig 2016 Unit 1: DNA and the Genome Sub-Topic (1.4) Cellular Differentiation On completion of this subtopic I will be able to Cellular

More information

Regenerative Medicine and Stem Cell Therapies

Regenerative Medicine and Stem Cell Therapies Regenerative Medicine and Stem Cell Therapies Regenerative Medicine Major component of successful regenerated / tissue engineered organs Scaffolds A critical element is the binding of the repopulating

More information

ANNOUNCEMENTS. HW2 is due Thursday 2/4 by 12:00 pm. Office hours: Monday 12:50 1:20 (ECCH 134)

ANNOUNCEMENTS. HW2 is due Thursday 2/4 by 12:00 pm. Office hours: Monday 12:50 1:20 (ECCH 134) ANNOUNCEMENTS HW2 is due Thursday 2/4 by 12:00 pm. Office hours: Monday 12:50 1:20 (ECCH 134) Lectures 6 8 Outline Stem Cell Division - symmetric - asymmetric Stem cell lineage potential - pluripotent

More information

Regulation of advanced blood cell therapies

Regulation of advanced blood cell therapies Regulation of advanced blood cell therapies www.pei.de Clinical trials using cell-based products Substantially manipulated cells and cells for non-homologous use Quality, safety and non-clinical aspects

More information

ANAT 3231 Cell Biology Lecture 21 Stem Cells

ANAT 3231 Cell Biology Lecture 21 Stem Cells ANAT 3231 Cell Biology Lecture 21 Stem Cells Outline What are Stem Cells? Totipotency - Pluripotency - Multipotency What are different sources of Stem Cells? Embryonic vs Adult Pros and Cons for each type

More information

UNIT CELL PROCESSES UNDERLYING TISSUE ENGINEERING AND REGENERATIVE MEDICINE

UNIT CELL PROCESSES UNDERLYING TISSUE ENGINEERING AND REGENERATIVE MEDICINE Massachusetts Institute of Technology Harvard Medical School Brigham and Women s Hospital VA Boston Healthcare System 2.79J/3.96J/20.441/HST522J UNIT CELL PROCESSES UNDERLYING TISSUE ENGINEERING AND REGENERATIVE

More information

Follicusan DP. Prevents accelerated Hair Loss. CLR - Chemisches Laboratorium Dr. Kurt Richter GmbH

Follicusan DP. Prevents accelerated Hair Loss. CLR - Chemisches Laboratorium Dr. Kurt Richter GmbH Prevents accelerated Hair Loss CLR - Chemisches Laboratorium Dr. Kurt Richter GmbH Introduction Milk based bioactive signaling molecules DL-Ethylpanthenol Inositol Sulfur-rich amino acids (N-acetyl-Cysteine,

More information

Induction of Hair Growth by Fibroblast-Secreted WNTs. Gail Naughton and Frank Zeigler Histogen, Inc.

Induction of Hair Growth by Fibroblast-Secreted WNTs. Gail Naughton and Frank Zeigler Histogen, Inc. Induction of Hair Growth by Fibroblast-Secreted WNTs Gail Naughton and Frank Zeigler Histogen, Inc. Fibroblast Secreted Factors Formed during tissue-engineering manufacturing process by primary human foreskin

More information

Social and Ethical Issues in Systems Biology. HW: pg 120 #1-5, 9-11, 14

Social and Ethical Issues in Systems Biology. HW: pg 120 #1-5, 9-11, 14 Social and Ethical Issues in Systems Biology HW: pg 120 #1-5, 9-11, 14 Transplanting Organs Organ transplantation involves the removal of an organ from donor body and placement in a recipient body, wherein

More information

Stem Cell. Running head: STEM CELL RESEARCH. Stem Cell Research. Student s Name. University Affiliation

Stem Cell. Running head: STEM CELL RESEARCH. Stem Cell Research. Student s Name. University Affiliation 1 Running head: STEM CELL RESEARCH Stem Cell Research Student s Name University Affiliation 2 Stem Cell Research Stem cell research is the subject of many current researches and studies all over the world.

More information

Considerations in Product Development with Advanced Therapies and Cancer Vaccines

Considerations in Product Development with Advanced Therapies and Cancer Vaccines Considerations in Product Development with Advanced Therapies and Cancer Vaccines Thomas Hinz Head of Section Therapeutic Vaccines Paul-Ehrlich-Institut hinth@pei.de Thomas Hinz, October 29, 2008, San

More information

How You Can Use Stem Cells

How You Can Use Stem Cells How You Can Use Stem Cells Dr. Ralph T Bright Macquarie Cosmetic Medicine 21B Bathurst Street Liverpool NSW 2170 www.cosmeticmedicine.com.au (02) 9824 3044 Stem Cell Transfer Many of the people in this

More information

BIOTECHNOLOGY. Unit 8

BIOTECHNOLOGY. Unit 8 BIOTECHNOLOGY Unit 8 PART 1 BASIC/FUNDAMENTAL SCIENCE VS. APPLIED SCIENCE! Basic/Fundamental Science the development and establishment of information to aid our understanding of the world.! Applied Science

More information

Chapter 8 Healthcare Biotechnology

Chapter 8 Healthcare Biotechnology Chapter 8 Healthcare Biotechnology Outline: 8.1 Introduction 8.2 Biopharming 8.3 Models of Human Disease 8.4 Detecting and Diagnosing Human Disease 8.5 Monoclonal Antibodies 8.6 Gene Therapy 8.7 Tissue

More information

Current situation on nonclinical safety evaluation of regenerative medical products in Japan

Current situation on nonclinical safety evaluation of regenerative medical products in Japan Current situation on nonclinical safety evaluation of regenerative medical products in Japan Takuya Nishimura Office of Cellular and Tissue based Products PMDA Disclaimers The views expressed in this presentation

More information

Scientists have successfully used stem cells to reverse this paralysis. Magnification 0.02

Scientists have successfully used stem cells to reverse this paralysis. Magnification 0.02 1 The photograph below shows an X-ray of a dachshund. The dachshund is a breed of dog that is at higher risk of paralysis due to spinal injury. Scientists have successfully used stem cells to reverse this

More information

Energy for Today. Opportunities for Tomorrow. July 2018

Energy for Today. Opportunities for Tomorrow. July 2018 Energy for Today. Opportunities for Tomorrow. July 2018 2 DIVERSIFIED, GROWTH-ORIENTED VENTURE COMPANY PURSUING OPPORTUNITIES IN SOLAR ENERGY Exchange Listings CNSX (Canadian National Stock Exchange):

More information

Des cellules-souches dans le poumon : pourquoi faire?

Des cellules-souches dans le poumon : pourquoi faire? Des cellules-souches dans le poumon : pourquoi faire? Karl-Heinz Krause Dept. of Pathology and Immunology, Medical Faculty Dept. of Genetic and Laboratory Medicine, University Hospitals Geneva, Switzerland

More information

YOUR OWN LIFE

YOUR OWN LIFE YOUR OWN LIFE Stromal Tissue (ST), a Regenerative Source There is a worldwide consensus that the isolation and collection of regenerative Mesenchymal Stem Cells (MSC s) from differentiated body tissues

More information

Characteristics. Capable of dividing and renewing themselves for long periods of time (proliferation and renewal)

Characteristics. Capable of dividing and renewing themselves for long periods of time (proliferation and renewal) STEM CELLS (p 2-8) Overview The body is made up of about 200 different kinds of specialised cells, such as muscle cells, nerve cells, fat cells and skin cells. Cells with the capacity to give rise to the

More information

Towards a stem cell based therapy for Parkinson s Disease

Towards a stem cell based therapy for Parkinson s Disease Stem cell based therapies for Parkinson s Disease Towards a stem cell based therapy for Parkinson s Disease MALIN PARMAR NYSCF Robertson Investigator Lund University, Sweden INTR, Port Douglas, Sept 13-16,

More information

Lesson 7A Specialized Cells, Stem Cells & Cellular Differentiation

Lesson 7A Specialized Cells, Stem Cells & Cellular Differentiation Lesson 7A Specialized Cells, Stem Cells & Cellular Differentiation Learning Goals I can explain the concept of cell differentiation and cell specialization. I can explain how the cell structure relates

More information

Stem Cell Principle -

Stem Cell Principle - Effective Date: 31.10.2017 Doc ID: 20290214 Version: 1.0 Status: Approved Planned Effective Date: 31-Oct-2017 00:00 CET (Server Date) Stem Cell Principle - Rationale Research on human stem cells and their

More information

Adult Stem Cells for Chronic Pain. Dr. John Hughes, DO January 24 th, 2018

Adult Stem Cells for Chronic Pain. Dr. John Hughes, DO January 24 th, 2018 Adult Stem Cells for Chronic Pain Dr. John Hughes, DO January 24 th, 2018 Dr. John Hughes, DO Doctor of Osteopathy From Georgia Arizona College of Osteopathic Medicine - 2007 Aspen Integrative Medicine

More information

Stem cell dialogue: key findings, conclusions and recommendations. Dr Darren Bhattachary, Director BMRB

Stem cell dialogue: key findings, conclusions and recommendations. Dr Darren Bhattachary, Director BMRB Stem cell dialogue: key findings, conclusions and recommendations Dr Darren Bhattachary, Director BMRB Objectives Engage the public and stakeholders on stem cells: policy development Views and concerns

More information

6th Form Open Day 15th July 2015

6th Form Open Day 15th July 2015 6th Form Open Day 15 th July 2015 DNA is like a computer program but far, far more advanced than any software ever created. Bill Gates Welcome to the Open Day event at the Institute of Genetic Medicine

More information

Stem cells in Development

Stem cells in Development ANAT 2341 Embryology Lab 10 8 Oct 2009 Therapeutic Use of Stem Cells Practical Hurdles & Ethical Issues Stem cells in Development Blastocyst Cord blood Antonio Lee PhD Neuromuscular & Regenerative Medicine

More information

Stem Cells & Neurological Disorders. Said Ismail Faculty of Medicine University of Jordan

Stem Cells & Neurological Disorders. Said Ismail Faculty of Medicine University of Jordan Stem Cells & Neurological Disorders Said Ismail Faculty of Medicine University of Jordan Outline: - Introduction - Types & Potency of Stem Cells - Embryonic Stem Cells - Adult Stem Cells - ipscs -Tissue

More information

INTESTINAL ORGANOIDS. IntestiCult and STEMdiff Media for Intestinal Organoid Culture. Scientists Helping Scientists

INTESTINAL ORGANOIDS. IntestiCult and STEMdiff Media for Intestinal Organoid Culture. Scientists Helping Scientists INTESTINAL ORGANOIDS IntestiCult and STEMdiff Media for Intestinal Organoid Culture Scientists Helping Scientists WWW.STEMCELL.COM CULTURING INTESTINAL ORGANOIDS TABLE OF CONTENTS 3 Introduction 4 IntestiCult

More information

Stem cells in Development

Stem cells in Development ANAT 2341 Embryology Lab 10 8 Oct 2009 Therapeutic Use of Stem Cells Practical Hurdles & Ethical Issues Stem cells in Development Blastocyst Cord blood Antonio Lee PhD Neuromuscular & Regenerative Medicine

More information

Ex Vivo Imaging and Genetic Manipulation of Mouse Hair Follicle Bulge Stem Cells

Ex Vivo Imaging and Genetic Manipulation of Mouse Hair Follicle Bulge Stem Cells Methods in Molecular Biology DOI 10.1007/7651_2018_136 Springer Science+Business Media New York 2018 Ex Vivo Imaging and Genetic Manipulation of Mouse Hair Follicle Bulge Stem Cells Daniel Haensel, Melissa

More information

Stem Cell Research 101

Stem Cell Research 101 Stem Cell Research : A promising type of bioscience research The Stem Cell debate and the impact of the induced pluripotent stem cell procedure Why Is Vocabulary Important? Key terms frame the debate Mature

More information

Supplementary Materials for

Supplementary Materials for advances.sciencemag.org/cgi/content/full/1/9/e1500973/dc1 Supplementary Materials for Pharmacologic inhibition of JAK-STAT signaling promotes hair growth Sivan Harel, Claire A. Higgins, Jane E. Cerise,

More information

Epidermal stem cells and skin tissue engineering in hair follicle regeneration

Epidermal stem cells and skin tissue engineering in hair follicle regeneration Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4252/wjsc.v7.i4.711 World J Stem Cells 2015 May 26; 7(4): 711-727 ISSN 1948-0210 (online) 2015

More information

European Regenerative Medicine Firms & Their Strategic Approaches. Michael Morrison University of York

European Regenerative Medicine Firms & Their Strategic Approaches. Michael Morrison University of York European Regenerative Medicine Firms & Their Strategic Approaches Michael Morrison University of York OVERVIEW Creating the European RM Universe of firms Characterizing the European RM Universe Strategic

More information

Future of Stem Cell Engineering. Jaeseung Jeong, Ph.D Department of Bio and Brain Engineering KAIST

Future of Stem Cell Engineering. Jaeseung Jeong, Ph.D Department of Bio and Brain Engineering KAIST Future of Stem Cell Engineering i Jaeseung Jeong, Ph.D Department of Bio and Brain Engineering KAIST Keywords of Stem Cell Engineering g Embryo and Fetus (Foetus) Adult stem cells and embryonic stem cells

More information

Yoji SATO, Ph.D. Head, Division of Cellular & Gene Therapy Products National Institute of Health Sciences, Tokyo, Japan

Yoji SATO, Ph.D. Head, Division of Cellular & Gene Therapy Products National Institute of Health Sciences, Tokyo, Japan NIHS Since 1874 Yoji SATO, Ph.D. Head, Division of Cellular & Gene Therapy Products National Institute of Health Sciences, Tokyo, Japan October 21, 2013 DISCLAIMER: The views and opinions expressed in

More information

Topical sirna for management of androgenic alopecia and oily skin Quark Pharmaceuticals, Inc.

Topical sirna for management of androgenic alopecia and oily skin Quark Pharmaceuticals, Inc. Topical sirna for management of androgenic alopecia and oily skin 1 2017 Quark Pharmaceuticals, Inc. About Quark Founded in 1993; privately held Late stage pharmaceutical company with 2 Phase 3 programs,

More information

Lisa Griffin (BSc Hons Biology), David Hughes August 2013

Lisa Griffin (BSc Hons Biology), David Hughes August 2013 Title Authors Contact Target level Publication date Lisa Griffin (BSc Hons Biology), David Hughes Maggy.fostier@manchester.ac.uk KS4 science, GCSE August 2013 Activity Length Content related to the GCSE

More information

Monitoring the Safety of Stem Cell Based Therapeutics in Clinical Trials. Jane Lebkowski Ph.D. ASGCT May 18, 2010

Monitoring the Safety of Stem Cell Based Therapeutics in Clinical Trials. Jane Lebkowski Ph.D. ASGCT May 18, 2010 Monitoring the Safety of Stem Cell Based Therapeutics in Clinical Trials Jane Lebkowski Ph.D. ASGCT May 18, 2010 Disclosure Received salary & ownership interest from Geron Corporation as an employee. Multiple

More information

APPLICATION FORM. Application for a Recognised Research Ethics Committee (REC) Opinion on a Clinical Trial on a Medicinal Product for Human Use.

APPLICATION FORM. Application for a Recognised Research Ethics Committee (REC) Opinion on a Clinical Trial on a Medicinal Product for Human Use. APPLICATION FORM Application for a Recognised Research Ethics Committee (REC) Opinion on a Clinical Trial on a Medicinal Product for Human Use. Form 1 This application form should be completed and submitted

More information

Stem Cells, Regenerative Medicine and cgmp (GTP)

Stem Cells, Regenerative Medicine and cgmp (GTP) Stem Cells, Regenerative Medicine and cgmp (GTP) Encompass Stem cell based therapies activities Collection source Purification Isolation from other cell types if needed Manipulation Minimal vs Moderate

More information

Stem Cells: Ethics and Oversight May 24, Sidney H. Golub, Ph.D. Interim Director Sue & Bill Gross Stem Cell Research Center

Stem Cells: Ethics and Oversight May 24, Sidney H. Golub, Ph.D. Interim Director Sue & Bill Gross Stem Cell Research Center Stem Cells: Ethics and Oversight May 24, 2017 Sidney H. Golub, Ph.D. Interim Director Sue & Bill Gross Stem Cell Research Center Nobel Laureates 2012 John Gurdon Shinya Yamanaka Pluripotent Stem Cell PLURIPOTENT

More information

Project Report in Experts in Teamwork. TBT Stem Cells Studies: Research and Ethical Aspects

Project Report in Experts in Teamwork. TBT Stem Cells Studies: Research and Ethical Aspects Project Report in Experts in Teamwork TBT4850 - Stem Cells Studies: Research and Ethical Aspects Participants: Jin Su Line Syslak Marit Carlsen Romfo Martin Velje Andersen Birgitte Hjelmeland McDonagh

More information

Cell-based therapies in tissue engineering and regenerative medicine (TE/RM)

Cell-based therapies in tissue engineering and regenerative medicine (TE/RM) Cell-based therapies in tissue engineering and regenerative medicine (TE/RM) Pamela Gehron Robey, Ph.D. Craniofacial and Skeletal Diseases Branch National Institutes of Dental and Craniofacial Research

More information

Stem Cell Services. Driving Innovation for Stem Cell Researchers

Stem Cell Services. Driving Innovation for Stem Cell Researchers Driving Innovation for Stem Cell Researchers Stem Cell Services Partner with us and have access to the most advanced and comprehensive stem cell services available today. 675 W. Kendall St. Cambridge,

More information

Current Japanese Regulation for Cell Therapy and NCC strategy

Current Japanese Regulation for Cell Therapy and NCC strategy Current Japanese Regulation for Cell Therapy and NCC strategy National Cancer Center Hospital Department of Medical Oncology Division of Cell and Gene Therapy Yuji Heike Today s topics 1)Current Regulation

More information

PRIME-XV Cell Therapy Products by

PRIME-XV Cell Therapy Products by PRIME-XV Cell Therapy Products by Product List 2017 TRINOVA BIOCHEM now distributes the PRIME-XV Cell Therapy line by Irvine Scientific in Germany, Austria and Switzerland. Irvine Scientific is a worldwide

More information

Stem cells and tissue engineering

Stem cells and tissue engineering Stem cells and tissue engineering S. Swaminathan Director Centre for Nanotechnology & Advanced Biomaterials School of Chemical & Biotechnology SASTRA University Thanjavur 613 401 Tamil Nadu Joint Initiative

More information

FREQUENTLY ASKED QUESTIONSON STEM CELLS AND THEIR CLINICAL APPLICATIONS/THERAPY

FREQUENTLY ASKED QUESTIONSON STEM CELLS AND THEIR CLINICAL APPLICATIONS/THERAPY FREQUENTLY ASKED QUESTIONSON STEM CELLS AND THEIR CLINICAL APPLICATIONS/THERAPY Basics of Stem Cells 1) What is a cell? Cell is the building block of our body. It is the smallest structural and functional

More information

Treating Functional Cellular Deficits. Stem Cell on the Mesa

Treating Functional Cellular Deficits. Stem Cell on the Mesa Treating Functional Cellular Deficits Stem Cell on the Mesa October 2014 Safe Harbor Statements Statements included in this presentation that do not relate to present or historical conditions are forward

More information

Xeno-Free Systems for hesc & hipsc. Facilitating the shift from Stem Cell Research to Clinical Applications

Xeno-Free Systems for hesc & hipsc. Facilitating the shift from Stem Cell Research to Clinical Applications Xeno-Free Systems for hesc & hipsc Facilitating the shift from Stem Cell Research to Clinical Applications NutriStem Defined, xeno-free (XF), serum-free media (SFM) specially formulated for growth and

More information

Genetics Lecture 19 Stem Cells. Stem Cells 4/10/2012

Genetics Lecture 19 Stem Cells. Stem Cells 4/10/2012 Genetics Lecture 19 Stem Cells Stem Cells Much of the excitement about stem cells in the scientific and medical communities comes from their largely untapped and unproven potential for treating human conditions)

More information

ISTINYE UNIVERSITY INSTITUTE OF HEALTH SCIENCES DEPARTMENT OF STEM CELL AND TISSUE ENGINEERING (THESIS) COURSE DESCRIPTIONS

ISTINYE UNIVERSITY INSTITUTE OF HEALTH SCIENCES DEPARTMENT OF STEM CELL AND TISSUE ENGINEERING (THESIS) COURSE DESCRIPTIONS ISTINYE UNIVERSITY INSTITUTE OF HEALTH SCIENCES DEPARTMENT OF STEM CELL AND TISSUE ENGINEERING (THESIS) COURSE DESCRIPTIONS 1 st SEMESTER Adult Stem Cell Biology 5 ECTS In this course, the characteristics

More information

October 23 & 24, 2018

October 23 & 24, 2018 Tuesday, October 23, 2018 8:30 AM REGISTRATION AND COMPLIMENTARY BREAKFAST 9:00 AM Introduction: Susan L. Solomon, JD The NYSCF Research Institute 9:05 AM Welcome Remarks: Richard Lifton, MD, PhD TISSUE

More information

STEM CELL ETHICS: THE NEGLECTED ISSUES. Dr. Christie Holland Rev. Dr. Karen Lebacqz

STEM CELL ETHICS: THE NEGLECTED ISSUES. Dr. Christie Holland Rev. Dr. Karen Lebacqz STEM CELL ETHICS: THE NEGLECTED ISSUES Dr. Christie Holland Rev. Dr. Karen Lebacqz Stem Cell Science -- some basic terms totipotent = able to make an entire organism. pluripotent = able to make all types

More information

PRIME-XV Cell Therapy Products by

PRIME-XV Cell Therapy Products by PRIME-XV Cell Therapy Products by Product List 2017 TRINOVA BIOCHEM now distributes the PRIME-XV Cell Therapy line by Irvine Scientific in Germany, Austria and Switzerland. Irvine Scientific is a worldwide

More information

Exposition of New Regulation in the Revision of Pharmaceutical Affairs Law For Correct Understanding of Conditional & Time Limited Approval

Exposition of New Regulation in the Revision of Pharmaceutical Affairs Law For Correct Understanding of Conditional & Time Limited Approval The contents of this presentation represent the view of this presenter only, and do not represent the views and/or policies of the PMDA Exposition of New Regulation in the Revision of Pharmaceutical Affairs

More information

Cellular and Gene Therapy Products - CBER Update

Cellular and Gene Therapy Products - CBER Update DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTER FOR BIOLOGICS EVALUATION and RESEARCH Cellular and Gene Therapy Products - CBER Update Well Characterized Biological Products January 12-14, 2009 Kimberly

More information

Name of Journal: World Journal of Experimental Medicine ESPS Manuscript NO: Manuscript Type: ORIGINAL ARTICLE

Name of Journal: World Journal of Experimental Medicine ESPS Manuscript NO: Manuscript Type: ORIGINAL ARTICLE Name of Journal: World Journal of Experimental Medicine ESPS Manuscript NO: 25814 Manuscript Type: ORIGINAL ARTICLE Comments Response Reviewer 1 Authors studied differentiation of hescs cell line into

More information

Developing Targeted Stem Cell Therapeutics for Cancer. Shawn Hingtgen, Ph.D. Assistant Professor UNC Eshelman School of Pharmacy May 22 nd, 2013

Developing Targeted Stem Cell Therapeutics for Cancer. Shawn Hingtgen, Ph.D. Assistant Professor UNC Eshelman School of Pharmacy May 22 nd, 2013 Developing Targeted Stem Cell Therapeutics for Cancer Shawn Hingtgen, Ph.D. Assistant Professor UNC Eshelman School of Pharmacy May 22 nd, 2013 The Challenge of Drug Delivery for Brain Cancer Stem Cells

More information

NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY:

NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY: NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY: Potent biological scaffolds strategically control stem cell fate and function, allowing our allografts to harness the regenerative potential of patient s

More information

Will Stem Cells Finally Deliver Without Controversy?

Will Stem Cells Finally Deliver Without Controversy? Will Stem Cells Finally Deliver Without Controversy? Keith Gary, Ph.D. Director of Program Development Kansas City Area Life Sciences Institute Olathe North Life Sciences 1 February 2012 What s the Buzz?

More information

EMA s role & responsibility for the development of modern/advanced therapies

EMA s role & responsibility for the development of modern/advanced therapies EMA s role & responsibility for the development of modern/advanced therapies Agenda Current regulatory picture Overall Regulatory framework New Committee at EMA Current Activities & Challenges Egbert Flory

More information

possibilities for replacing living animals Eszter Tuboly Assistant Professor Institute of Surgical Research

possibilities for replacing living animals Eszter Tuboly Assistant Professor Institute of Surgical Research Animal experiments- In vitro possibilities for replacing living animals Eszter Tuboly Assistant Professor Institute of Surgical Research Alternatives Replacement is needed Social assessment, growing demand

More information

The New News in Stem Cell Research Andrés Bratt-Leal, PhD 12/1/2017

The New News in Stem Cell Research Andrés Bratt-Leal, PhD 12/1/2017 The New News in Stem Cell Research Andrés Bratt-Leal, PhD 12/1/2017 Cell Therapy and Parkinson s Disease Very specific neural degeneration >50% of DA neurons are gone by diagnosis 1 million in the USA,

More information

The European Research Council. CRISPR-Cas9 research in ERCEA Ethics Process. Filipa Ferraz de Oliveira ERCEA Scientific Officer

The European Research Council. CRISPR-Cas9 research in ERCEA Ethics Process. Filipa Ferraz de Oliveira ERCEA Scientific Officer The European Research Council CRISPR-Cas9 research in ERCEA Ethics Process Filipa Ferraz de Oliveira ERCEA Scientific Officer Fostering Responsible Research With CRISPR-Cas9, Paris, March 2016 1 CRISPR-Cas9

More information

Discover TruPRP. PRP the way you want it.

Discover TruPRP. PRP the way you want it. Discover TruPRP PRP the way you want it. Discover TruPRP Discover the quality of Magellan TruPRP. The Magellan technology provides an automated dual spin processing system that can deliver (PRP) Platelet

More information

RXi Pharmaceuticals. BioPharm America September 26, 2017 NASDAQ: RXII. Property of RXi Pharmaceuticals

RXi Pharmaceuticals. BioPharm America September 26, 2017 NASDAQ: RXII. Property of RXi Pharmaceuticals RXi Pharmaceuticals BioPharm America September 26, 2017 NASDAQ: RXII Forward Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation

More information

IRB USE ONLY Approval Date: September 10, 2013 Expiration Date: September 10, 2014

IRB USE ONLY Approval Date: September 10, 2013 Expiration Date: September 10, 2014 Approval : September 10, 2013 Expiration : September 10, 2014 DESCRIPTION: You are invited to donate your excess sperm and/or testicular biopsy material, as well as your somatic cells (ordinary body cells

More information

CLINICAL TRIAL AUTHORIZATION APPLICATION FORM

CLINICAL TRIAL AUTHORIZATION APPLICATION FORM CLINICAL TRIAL AUTHORIZATION APPLICATION FORM Date of Receipt: Date of Triage : Date of valid application: Type of CTC review: NHRA CTA Number: ICTR/ITN Number: Date of Verification of ICTR/ITN: THIS SECTION

More information

Regulatory framework for Stem Cell and Products review in India. Presentation By: Dr. V G Somani Joint Drugs Controller (India) CDSCO (HQ)

Regulatory framework for Stem Cell and Products review in India. Presentation By: Dr. V G Somani Joint Drugs Controller (India) CDSCO (HQ) Regulatory framework for Stem Cell and Products review in India Presentation By: Dr. V G Somani Joint Drugs Controller (India) CDSCO (HQ) 1 Outline of Presentation Legal Provisions MCI Code of Ethics regulation

More information

Fundamental properties of Stem Cells

Fundamental properties of Stem Cells Stem cells Learning Goals: Define what a stem cell is and describe its general properties, using hematopoietic stem cells as an example. Describe to a non-scientist the current progress of human stem cell

More information

CBER Regulation of Devices for Cell Therapy

CBER Regulation of Devices for Cell Therapy CBER Regulation of Devices for Cell Therapy Richard D. McFarland, Ph.D., M.D. Associate Director for Policy Office of Cellular, Tissue and Gene Therapies Center for Biologics Evaluation and Research Food

More information

The EU Regulatory Framework for the ATMP

The EU Regulatory Framework for the ATMP The EU Regulatory Framework for the ATMP Disclaimer I attend this course as an individual expert, and do not represent EMA or ISS. The views expressed here are my personal views, and may not be understood

More information

Stem cell: a cell capable of 1) tissue plasticity - make different cell types 2) infinite self renewal through asymmetric division

Stem cell: a cell capable of 1) tissue plasticity - make different cell types 2) infinite self renewal through asymmetric division Stem cell: a cell capable of 1) tissue plasticity - make different cell types 2) infinite self renewal through asymmetric division stem cell stem cell skin muscle nerve Properties of STEM cells Plasticity

More information

Stem cells and motor neurone disease

Stem cells and motor neurone disease Stem cells and motor neurone disease F Stem cell research has fuelled hope of a treatment for a variety of conditions. This information sheet explains what these cells are and includes details of the current

More information

Patient Handbook on Stem Cell Therapies

Patient Handbook on Stem Cell Therapies Patient Handbook on Stem Cell Therapies WWW.ISSCR.ORG WWW.CLOSERLOOKATSTEMCELLS.ORG Patient Handbook on Stem Cell Therapies Introduction We have all heard about the extraordinary promise that stem cell

More information

Cell therapies to treat haematopoietic disorders

Cell therapies to treat haematopoietic disorders Cell therapies to treat haematopoietic disorders Haematopoietic Stem Cells (CD34) RBCs Platelets Limitations A donor required for each treatment Transfusion-transmitted infection Immunological (HLA/AB0)

More information

10:10-10:22. YIA-1 A study of newly established human peripheral blood monocyte-derived ips cell line used in allergy research 10:22-10:32

10:10-10:22. YIA-1 A study of newly established human peripheral blood monocyte-derived ips cell line used in allergy research 10:22-10:32 10:10-10:22 YIA-1 A study of newly established human peripheral blood monocyte-derived ips cell line used in allergy research 10:22-10:32 EPA-1 Integration of conventional cell viability assays- recruiting

More information

within EudraCT; important data such as phase I clinical trials in adults are, however, not publicly

within EudraCT; important data such as phase I clinical trials in adults are, however, not publicly Online Materials and Methods EudraCT version All data analyzed for our study resulted from queries performed from the EudraCT database, current Version 8.1.1. Version 8 of EudraCT was released in March

More information

Dec 04, 2013

Dec 04, 2013 Stem Cells Junfeng Ji ( 纪俊峰 ), PhD Professor Research Center of Stem Cell and Developmental Biology School of Medicine Zhejiang University Email: jijunfeng@zju.edu.cn Dec 04, 2013 Totipotent Pluripotent

More information

Introduction to SmartX

Introduction to SmartX New Solution for Stem Cell Therapy Introduction to SmartX DongKoo Bio&Pharma Co.,Ltd. 01 Definition What is a Stem Cell? Stem cell is capable of differentiating into various cell types of organs or tissues,

More information

Regulatory science insights into cellular products and practical microscale technologies for their assessment

Regulatory science insights into cellular products and practical microscale technologies for their assessment Regulatory science insights into cellular products and practical microscale technologies for their assessment Kyung Sung Johnny Lam November 9, 2018 Cellular and Tissue Therapies Branch Division of Cellular

More information

Specifications. February 19, 2015, TOKYO, JAPAN. Takao Hayakawa, Ph.D. Director, Pharmaceutical Research and Technology Institute, Kindai University

Specifications. February 19, 2015, TOKYO, JAPAN. Takao Hayakawa, Ph.D. Director, Pharmaceutical Research and Technology Institute, Kindai University Specifications February 19, 2015, TOKYO, JAPAN Takao Hayakawa, Ph.D. Director, Pharmaceutical Research and Technology Institute, Kindai University Norihisa Sakamoto, M.D., Ph.D. Deputy Review Director

More information

"From Bedside to Bench and Back: regulatory requirements for collaborations between pharma industry and academia

From Bedside to Bench and Back: regulatory requirements for collaborations between pharma industry and academia "From Bedside to Bench and Back: regulatory requirements for collaborations between pharma industry and academia Damir Hamamdžić D.V.M., Ph.D. Office of Research Regulatory Affairs Rutgers University RWJMS

More information

Gene therapy. Findings by Alert

Gene therapy. Findings by Alert Gene therapy Published Mar 21, 2000 Version 1 Findings by Alert Research in gene therapy has increased dramatically during the past 15 years, particularly in the United States. The research has encompassed

More information

Molecular Medicine. Stem cell therapy Gene therapy. Immunotherapy Other therapies Vaccines. Medical genomics

Molecular Medicine. Stem cell therapy Gene therapy. Immunotherapy Other therapies Vaccines. Medical genomics Molecular Medicine Molecular Medicine Stem cell therapy Gene therapy Tumor therapy Immunotherapy Other therapies Vaccines Genetic diagnostics Medical genomics Medication Diagnostics medicine: old desire

More information

Stem cells and cell therapy

Stem cells and cell therapy Stem cells and cell therapy lecture 7-15.05.2012 What is a stem cell? Stem cell can differentiate into two or more cell types Progenitor cells differentiates into single cell type 2 Sources of stem or

More information